home / stock / indp / indp quote
Last: | $2.005 |
---|---|
Change Percent: | 1.29% |
Open: | $2 |
Close: | $2.005 |
High: | $2.1618 |
Low: | $1.9801 |
Volume: | 11,564 |
Last Trade Date Time: | 05/02/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$2.005 | $2 | $2.005 | $2.1618 | $1.9801 | 11,564 | 05-02-2024 |
$2.0262 | $2.26 | $2.0262 | $2.28 | $1.9719 | 21,160 | 05-01-2024 |
$2.17 | $2.14 | $2.17 | $2.2271 | $2.14 | 4,847 | 04-30-2024 |
$2.1218 | $2.25 | $2.1218 | $2.25 | $2.06 | 7,724 | 04-29-2024 |
$2.11 | $2.22 | $2.11 | $2.22 | $2.0486 | 8,086 | 04-26-2024 |
$2.18 | $2.31 | $2.18 | $2.3227 | $2.15 | 29,204 | 04-25-2024 |
$2.35 | $2.45 | $2.35 | $2.67 | $2.255 | 49,596 | 04-24-2024 |
$2.49 | $2.68 | $2.49 | $2.68 | $2.47 | 7,352 | 04-23-2024 |
$2.44 | $2.3949 | $2.44 | $2.48 | $2.3941 | 4,186 | 04-22-2024 |
$2.36 | $2.49 | $2.36 | $2.555 | $2.34 | 10,645 | 04-19-2024 |
$2.52 | $2.58 | $2.52 | $2.63 | $2.45 | 27,005 | 04-18-2024 |
$2.66 | $2.74 | $2.66 | $2.74 | $2.35 | 25,174 | 04-17-2024 |
$2.7899 | $2.69 | $2.7899 | $2.7899 | $2.69 | 7,562 | 04-16-2024 |
$2.6174 | $2.95 | $2.6174 | $2.95 | $2.52 | 55,048 | 04-15-2024 |
$2.77 | $2.74 | $2.77 | $2.87 | $2.7108 | 53,983 | 04-12-2024 |
$2.75 | $2.54 | $2.75 | $2.75 | $2.45 | 94,037 | 04-11-2024 |
$2.5199 | $2.4799 | $2.5199 | $2.54 | $2.31 | 20,114 | 04-10-2024 |
$2.46 | $2.44 | $2.46 | $2.46 | $2.32 | 10,338 | 04-09-2024 |
$2.385 | $2.47 | $2.385 | $2.47 | $2.3111 | 13,301 | 04-08-2024 |
$2.44 | $2.25 | $2.44 | $2.4799 | $2.25 | 25,250 | 04-05-2024 |
News, Short Squeeze, Breakout and More Instantly...
Indaptus Therapeutics Inc. Company Name:
INDP Stock Symbol:
NASDAQ Market:
NEW YORK, April 11, 2024 (GLOBE NEWSWIRE) -- Indaptus Therapeutics, Inc, (Nasdaq: INDP), a clinical stage biotechnology company dedicated to pioneering innovative cancer and viral infection treatments, was proud to unveil its poster at the 2024 Annual Meeting of the American Association for Cance...
NEW YORK, March 28, 2024 (GLOBE NEWSWIRE) -- Indaptus Therapeutics, Inc. (NASDAQ:INDP), a clinical stage biotechnology company dedicated to pion...
Data demonstrates that Company's Decoy platform successfully induces or activates multiple immune cell types involved in anti-tumor response...